NOMAD POWER SOLUTIONS, INC. Current Assets
NOMAD POWER SOLUTIONS, INC. (NMAD) had Current Assets of $19.30 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-14
- 2026-06-30: Assets, Current $19.30M.
- 2026-03-31: Assets, Current $3.41M.
- 2025-12-31: Assets, Current $5.18M.
- 2025-09-30: Assets, Current $5.43M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $19.30M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $3.41M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $5.18M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $5.43M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $989.75K 10-Q · filed 2025-08-07 | |
| 2024-12-31 | $1.15M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $1.69M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $2.67M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $3.59M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $4.31M 10-Q · filed 2024-11-12 | |
| 2023-09-30 | $5.23M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $3.10M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $4.33M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $5.56M 10-K · filed 2024-03-19 | $5.56M 10-K · filed 2023-03-29 |
| 2022-09-30 | $6.82M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $8.02M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $4.11M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $5.09M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $6.31M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $7.24M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $7.89M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $5.23M 10-K · filed 2022-03-21 | |
| 2020-09-30 | $1.19M 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $1.80M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $2.28M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $2.67M 10-K · filed 2021-03-26 | |
| 2019-09-30 | $3.07M 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $3.62M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $3.95M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $4.33M 10-K · filed 2020-03-25 | |
| 2018-09-30 | $440.34K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $575.89K 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $854.56K 10-Q · filed 2018-04-27 | |
| 2017-12-31 | $1.37M 10-K · filed 2019-03-25 | |
| 2017-09-30 | $1.65M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $2.06M 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $920.57K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $433.41K 10-K · filed 2018-03-23 | |
| 2016-09-30 | $933.56K 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $1.38M 10-Q · filed 2016-08-10 | |
| 2016-03-31 | $1.22M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $597.98K 10-K · filed 2017-03-29 | |
| 2015-09-30 | $1.03M 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $1.52M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $1.68M 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $539.30K 10-K · filed 2016-03-28 | |
| 2014-09-30 | $996.17K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $1.30M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $187.87K 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $558.04K 10-K · filed 2015-03-27 | |
| 2013-09-30 | $873.82K 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $1.14M 10-Q · filed 2013-08-05 | |
| 2013-03-31 | $1.48M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $1.75M 10-K · filed 2014-03-21 | |
| 2012-09-30 | $1.96M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $2.25M 10-Q · filed 2012-08-10 | |
| 2012-03-31 | $201.57K 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $429.77K 10-K · filed 2013-03-15 | |
| 2011-09-30 | $1.00M 10-Q · filed 2011-11-10 | |
| 2011-06-30 | $1.42M 10-Q · filed 2011-08-12 | |
| 2010-12-31 | $1.93M 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |